Whole-body 68Ga-DOTANOC PET/MRI versus 68Ga-DOTANOC PET/CT in patients with neuroendocrine tumors: a prospective study in 28 patients
Purpose The aim of this study was to assess the diagnostic performance of simultaneous
whole-body 68 Ga-DOTANOC PET/MRI compared with 68 Ga-DOTANOC PET/CT for …
whole-body 68 Ga-DOTANOC PET/MRI compared with 68 Ga-DOTANOC PET/CT for …
Prognostic and predictive biomarkers in neuroendocrine tumours
Neuroendocrine tumours are extremely heterogeneous malignancies. Despite marked
heterogeneity in clinical course and prognosis, few biomarkers exist to help predict …
heterogeneity in clinical course and prognosis, few biomarkers exist to help predict …
Long-acting somatostatin analog therapy differentially alters 68Ga-DOTATATE uptake in normal tissues compared with primary tumors and metastatic lesions
Synthetic somatostatin analogs have been posed as a potential source of error in
somatostatin receptor imaging through interference with tumor detection; however …
somatostatin receptor imaging through interference with tumor detection; however …
Peptide Therapeutics: Unveiling the Potential against Cancer—A Journey through 1989
O Al Musaimi - Cancers, 2024 - mdpi.com
Simple Summary The extraordinary growth in the global pharmaceutical industry has
extended to include peptides, which are amino acids linked together with an amide bond …
extended to include peptides, which are amino acids linked together with an amide bond …
ACR–ACNM Practice Parameter for the Performance of Fluorine-18 Fluciclovine-PET/CT for Recurrent Prostate Cancer
B Savir-Baruch, KP Banks, JE McConathy… - Clinical nuclear …, 2018 - journals.lww.com
Abstract The American College of Radiology (ACR) and American College of Nuclear
Medicine (ACNM) collaborated to develop a clinical practice document for the performance …
Medicine (ACNM) collaborated to develop a clinical practice document for the performance …
[HTML][HTML] Diagnostic efficiency of 68Ga-DOTATATE PET/CT as compared to 99mTc-Octreotide SPECT/CT and conventional morphologic modalities in neuroendocrine …
Objective (s): In view of somatostatin receptor (SSR) expression on cell membranes of the
majority of neuroendocrine tumors (NETs), functional imaging exploiting analogs of SSR …
majority of neuroendocrine tumors (NETs), functional imaging exploiting analogs of SSR …
[HTML][HTML] Physiological biodistribution of 68Ga-DOTA-TATE in normal subjects
S Özgüven, N Filizoğlu, S Kesim… - Molecular imaging …, 2021 - ncbi.nlm.nih.gov
Objectives: Somatostatin is an endocrine peptide hormone that regulates neurotransmission
and cell proliferation by interacting with G protein-coupled somatostatin receptors (SSTRs) …
and cell proliferation by interacting with G protein-coupled somatostatin receptors (SSTRs) …
3-D image-based dosimetry in radionuclide therapy
M Ljungberg, KS Gleisner - IEEE Transactions on Radiation …, 2018 - ieeexplore.ieee.org
Radionuclide therapy is the use of radioactive drugs for internal radiotherapy, mainly for the
treatment of metastatic disease. As opposed to systemic cancer therapies in general, the use …
treatment of metastatic disease. As opposed to systemic cancer therapies in general, the use …
Clinical applications of radiolabeled peptides for PET
Radiolabeled peptides are a valuable class of radiotracer that occupies the space between
small molecules and large biologics, and are able to exploit the advantages of both classes …
small molecules and large biologics, and are able to exploit the advantages of both classes …
Imaging in multiple endocrine neoplasia type 1: recent studies show enhanced sensitivities but increased controversies
T Ito, RT Jensen - International journal of endocrine oncology, 2016 - Taylor & Francis
In multiple endocrine neoplasia type 1 (MEN1) patients, a number of recent studies compare
the ability of different, new imaging modalities to existing modalities to localize the important …
the ability of different, new imaging modalities to existing modalities to localize the important …